# A Study in Patients With Advanced or Metastatic Cancer

> **NCT01115751** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 80 (estimated)

## Conditions studied

- Metastases, Neoplasm

## Interventions

- **DRUG:** LY2780301

## Key facts

- **NCT ID:** NCT01115751
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2012-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01115751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01115751, "A Study in Patients With Advanced or Metastatic Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01115751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*